{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:33:24Z","timestamp":1793741604734,"version":"4.6.1"},"reference-count":26,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>Background: Irisin, an exercise-induced myokine, has emerged as a potent neuroprotective factor, though a systematic synthesis of its role across neurological disorders is lacking. This review systematically evaluates clinical and preclinical evidence on irisin\u2019s association with neurological diseases and its underlying mechanisms. Methods: Following PRISMA 2020 guidelines, a systematic search of PubMed\/MEDLINE, Scopus, Web of Science, Embase, and Cochrane Library was conducted. The review protocol was prospectively registered in PROSPERO. Twenty-one studies were included, comprising predominantly preclinical evidence (n = 14), alongside clinical observational studies (n = 6), and a single randomized controlled trial (RCT) investigating irisin in cerebrovascular diseases, Parkinson\u2019s disease (PD), Alzheimer\u2019s disease (AD), and other neurological conditions. Eligible studies were original English-language research on irisin or FNDC5 and their neuroprotective effects, excluding reviews and studies without direct neuronal outcomes. Risk of bias was independently assessed using SYRCLE, the Newcastle\u2013Ottawa Scale, and RoB 2, where disagreements between reviewers were resolved through discussion and consensus. Results were synthesized narratively, integrating mechanistic, pre-clinical, and clinical evidence to highlight consistent neuroprotective patterns of irisin across disease categories. Results: Clinical studies consistently demonstrated that reduced circulating irisin levels predict poorer outcomes. Lower serum irisin was associated with worse functional recovery and post-stroke depression after ischemic stroke, while decreased plasma irisin in PD correlated with greater motor severity, higher \u03b1-synuclein, and reduced dopamine uptake. In AD, cerebrospinal fluid irisin levels were significantly correlated with global cognitive efficiency and specific domain performance, and correlation analyses within studies suggested a closer association with amyloid-\u03b2 pathology than with markers of general neurodegeneration. However, diagnostic accuracy metrics (e.g., AUC, sensitivity, specificity) for irisin as a standalone biomarker are not yet established. Preclinical findings revealed that irisin exerts neuroprotection through multiple mechanisms: modulating microglial polarization from pro-inflammatory M1 to anti-inflammatory M2 phenotype, suppressing NLRP3 inflammasome activation, enhancing autophagy, activating integrin \u03b1V\u03b25\/AMPK\/SIRT1 signaling, improving mitochondrial function, and reducing neuronal apoptosis. Irisin administration improved outcomes across models of stroke, PD, AD, postoperative cognitive dysfunction, and epilepsy. Conclusions: Irisin represents a critical mediator linking exercise to brain health, with consistent neuroprotective effects across diverse neurological conditions. Its dual ability to combat neuroinflammation and directly protect neurons, demonstrated in preclinical models, positions it as a promising therapeutic candidate for future investigation. Future research must prioritize the resolution of fundamental methodological challenges in irisin measurement, alongside investigating pharmacokinetics and sex-specific effects, to advance irisin toward rigorous clinical evaluation.<\/jats:p>","DOI":"10.3390\/neurolint18010015","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:35:52Z","timestamp":1767954952000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Multifaceted Role of Irisin in Neurological Disorders: A Systematic Review Integrating Preclinical Evidence with Clinical Observations"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5772-3830","authenticated-orcid":false,"given":"Foad","family":"Alzoughool","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa P.O. Box 13115, Jordan"},{"name":"Department of Nursing, Faculty of Health Sciences, Higher Colleges of Technology, Abu Dhabi P.O. Box 25026, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5759-4581","authenticated-orcid":false,"given":"Loai","family":"Alanagreh","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa P.O. Box 13115, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2196-017X","authenticated-orcid":false,"given":"Yousef","family":"Aljawarneh","sequence":"additional","affiliation":[{"name":"Department of Nursing, Faculty of Health Sciences, Higher Colleges of Technology, Abu Dhabi P.O. Box 25026, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham","family":"Zraigat","sequence":"additional","affiliation":[{"name":"Department of Nursing, Faculty of Health Sciences, Higher Colleges of Technology, Abu Dhabi P.O. Box 25026, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alzghool","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wuhan University, Wuhan 430072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alzoughool, F., Al-Zghoul, M.B., Ghanim, B.Y., Gollob, M., Idkaidek, N., and Qinna, N.A. (2022). The Role of Interventional Irisin on Heart Molecular Physiology. Pharmaceuticals, 15.","DOI":"10.3390\/ph15070863"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cmet.2013.09.008","article-title":"Exercise induces hippocampal BDNF through a PGC-1\u03b1\/FNDC5 pathway","volume":"18","author":"Wrann","year":"2013","journal-title":"Cell Metab."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lourenco, M.V., de Freitas, G.B., Raony, \u00cd., Ferreira, S.T., and De Felice, F.G. (2022). Irisin stimulates protective signaling pathways in rat hippocampal neurons. Front. Cell. Neurosci., 16.","DOI":"10.3389\/fncel.2022.953991"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41531-023-00453-9","article-title":"Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12974-022-02438-6","article-title":"Irisin ameliorates neuroinflammation and neuronal apoptosis through integrin \u03b1V\u03b25\/AMPK signaling pathway after intracerebral hemorrhage in mice","volume":"19","author":"Wang","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhu, C., Guo, J., Chen, Y., and Meng, C. (2020). The Neuroprotective Effect of Irisin in Ischemic Stroke. Front. Aging Neurosci., 12.","DOI":"10.3389\/fnagi.2020.588958"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2204835119","DOI":"10.1073\/pnas.2204835119","article-title":"Amelioration of pathologic \u03b1-synuclein-induced Parkinson\u2019s disease by irisin","volume":"119","author":"Kam","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"114201","DOI":"10.1016\/j.intimp.2025.114201","article-title":"Irisin promotes autophagy and attenuates NLRP3 inflammasome activation in Parkinson\u2019s disease","volume":"149","author":"Zhu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1007\/s12035-025-04801-z","article-title":"Exercise Ameliorates Dysregulated Mitochondrial Fission, Mitochondrial Respiration, and Neuronal Apoptosis in Parkinson\u2019s Disease Mice via the Irisin\/AMPK\/SIRT1 Pathway","volume":"62","author":"Li","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_10","first-page":"722","article-title":"Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson\u2019s disease","volume":"22","author":"Zarbakhsh","year":"2019","journal-title":"Iran J. Basic Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41591-018-0275-4","article-title":"Exercise-linked FNDC5\/irisin rescues synaptic plasticity and memory defects in Alzheimer\u2019s models","volume":"25","author":"Lourenco","year":"2019","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s42255-021-00438-z","article-title":"Exercise hormone irisin is a critical regulator of cognitive function","volume":"3","author":"Islam","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"110572","DOI":"10.1016\/j.neuropharm.2025.110572","article-title":"Irisin ameliorates cognitive impairment in a lipopolysaccharide-induced neuroinflammation mouse model by inhibiting the NLRP3 inflammasome pathway in microglia","volume":"278","author":"Zhang","year":"2025","journal-title":"Neuropharmacology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/nan.12711","article-title":"Irisin treatment lowers levels of phosphorylated tau in the hippocampus of pre-symptomatic female but not male htau mice","volume":"47","author":"Bretland","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"112545","DOI":"10.1016\/j.intimp.2024.112545","article-title":"Irisin attenuates acute glaucoma-induced neuroinflammation by activating microglia-integrin \u03b1V\u03b25\/AMPK and promoting autophagy","volume":"138","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ozdemir-Kumral, Z.N., Akg\u00fcn, T., Ha\u015fim, C., Ulusoy, E., Kalpak\u00e7\u0131o\u011flu, M.K., Y\u00fcksel, M.F., Okumu\u015f, T., Us, Z., Akak\u0131n, D., and Y\u00fcksel, M. (2024). Intracerebroventricular administration of the exercise hormone irisin or acute strenuous exercise alleviates epileptic seizure-induced neuroinflammation and improves memory dysfunction in rats. BMC Neurosci., 25.","DOI":"10.1186\/s12868-024-00884-x"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbi.2024.12.019","article-title":"Irisin reprograms microglia through activation of STAT6 and prevents cognitive dysfunction after surgery in mice","volume":"125","author":"Wang","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"154303","DOI":"10.1016\/j.cyto.2018.02.017","article-title":"Serum levels of irisin predict short-term outcomes in ischemic stroke","volume":"122","author":"Wu","year":"2019","journal-title":"Cytokine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-018-1177-6","article-title":"Decreased level of irisin, a skeletal muscle cell-derived myokine, is associated with post-stroke depression in the ischemic stroke population","volume":"15","author":"Tu","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_20","first-page":"857","article-title":"Effect of staged acupuncture on serum irisin level and neurological rehabilitation in patients with ischemic stroke","volume":"42","author":"Chen","year":"2022","journal-title":"Zhongguo Zhen Jiu"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103555","DOI":"10.1016\/j.nicl.2023.103555","article-title":"Relationship of irisin with disease severity and dopamine uptake in Parkinson\u2019s disease patients","volume":"41","author":"Shi","year":"2024","journal-title":"NeuroImage Clin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/acn3.70117","article-title":"Correlation Between Irisin and Cognitive Functions in Alzheimer Dementia","volume":"12","author":"Pignataro","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ana.26946","article-title":"Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease","volume":"96","author":"Dicarlo","year":"2024","journal-title":"Ann. Neurol."},{"key":"ref_24","first-page":"e12034","article-title":"Cerebrospinal fluid irisin correlates with amyloid-\u03b2, BDNF, and cognition in Alzheimer\u2019s disease","volume":"12","author":"Lourenco","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3233\/JAD-231347","article-title":"Plasma BDNF\/Irisin Ratio Associates with Cognitive Function in Older People","volume":"99","author":"Huang","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/18\/1\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:55:22Z","timestamp":1767956122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/18\/1\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["neurolint18010015"],"URL":"https:\/\/doi.org\/10.3390\/neurolint18010015","relation":{},"ISSN":["2035-8377"],"issn-type":[{"value":"2035-8377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}